Preeti Singh
About Preeti Singh
Data last updated:
Preeti Singh is a Director at Saraswati Hospital And Research Centre Private Limited (since 2019), Director at Trimorph Private Limited (since 2021) and Director at Neophyte Pharmaceuticals Private Limited (since 2016). The companies operate in Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹61.1 Lakh; the largest is Saraswati Hospital And Research Centre Private Limited at ₹40.3 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saraswati Hospital And Research Centre Private Limited U85100BR2009PTC014613 | Director | 01 Oct 2019 | 2009 | ₹40.3 Lakh (FY 2017) | Active |
| Trimorph Private Limited U85110BR2021PTC055094 | Director | 11 Nov 2021 | 2021 | ₹18.9 Lakh (FY 2025) | Active |
| Neophyte Pharmaceuticals Private Limited U74999BR2016PTC031554 | Director | 13 May 2016 | 2016 | ₹1.9 Lakh (FY 2024) | Active |
Board colleagues of Preeti Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyendra Kumar | 02678121 | Saraswati Hospital And Research Centre Private Limited , Trimorph Private Limited and 1 more | Managing Director |
| Chandresh Kumar | 08107824 | Neophyte Pharmaceuticals Private Limited | Director |
| Rohit Kumar | 08107826 | Neophyte Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Preeti Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Preeti Singh
Preeti Singh currently holds 3 directorships: Saraswati Hospital And Research Centre Private Limited (Director, since 01 Oct 2019, revenue ₹40.3 Lakh (FY 2017)); Trimorph Private Limited (Director, since 11 Nov 2021, revenue ₹18.9 Lakh (FY 2025)); Neophyte Pharmaceuticals Private Limited (Director, since 13 May 2016, revenue ₹1.9 Lakh (FY 2024)).
Preeti Singh was first appointed on 13 May 2016 as Director at Neophyte Pharmaceuticals Private Limited. The most recent appointment on record is 11 Nov 2021 at Trimorph Private Limited.
The 3 current companies of Preeti Singh that report revenue have a combined latest revenue of ₹61.1 Lakh: Saraswati Hospital And Research Centre Private Limited ₹40.3 Lakh (FY 2017); Trimorph Private Limited ₹18.9 Lakh (FY 2025); Neophyte Pharmaceuticals Private Limited ₹1.9 Lakh (FY 2024).
The current boards of Preeti Singh's companies include Satyendra Kumar (Saraswati Hospital And Research Centre Private Limited), Chandresh Kumar (Neophyte Pharmaceuticals Private Limited), Rohit Kumar (Neophyte Pharmaceuticals Private Limited).